Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Medtronic Plc’s stock clocked out at $101.97, down -0.06% from its previous closing price of $102.03. In other words, the price has decreased by -$0.06 from its previous closing price. On the day, 4.14 million shares were traded. MDT stock price reached its highest trading level at $102.905 during the session, while it also had its lowest trading level at $101.58.
Ratios:
To gain a deeper understanding of MDT’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.70 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.11. For the most recent quarter (mrq), Quick Ratio is recorded 1.80 and its Current Ratio is at 2.42. In the meantime, Its Debt-to-Equity ratio is 0.60 whereas as Long-Term Debt/Eq ratio is at 0.57.
On June 16, 2025, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $110.Leerink Partners initiated its Outperform rating on June 16, 2025, with a $110 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 19 ’25 when Smith Gregory L sold 30,000 shares for $101.95 per share. The transaction valued at 3,058,451 led to the insider holds 46,016 shares of the business.
Smith Gregory L bought 30,000 shares of MDT for $3,058,452 on Nov 19 ’25. On Sep 03 ’25, another insider, KIIL HARRY SKIP, who serves as the EVP & President Cardiovascular of the company, sold 8,605 shares for $91.58 each. As a result, the insider received 788,048 and left with 35,615 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDT now has a Market Capitalization of 130788360192 and an Enterprise Value of 151703994368. As of this moment, Medtronic’s Price-to-Earnings (P/E) ratio for their current fiscal year is 27.55, and their Forward P/E ratio for the next fiscal year is 16.67. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.52. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.76 while its Price-to-Book (P/B) ratio in mrq is 2.69. Its current Enterprise Value per Revenue stands at 4.365 whereas that against EBITDA is 15.847.
Stock Price History:
The Beta on a monthly basis for MDT is 0.72, which has changed by 0.21262181 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, MDT has reached a high of $106.33, while it has fallen to a 52-week low of $79.29. The 50-Day Moving Average of the stock is 5.87%, while the 200-Day Moving Average is calculated to be 12.50%.
Shares Statistics:
It appears that MDT traded 7.22M shares on average per day over the past three months and 9624320 shares per day over the past ten days. A total of 1.28B shares are outstanding, with a floating share count of 1.28B. Insiders hold about 0.07% of the company’s shares, while institutions hold 87.10% stake in the company. Shares short for MDT as of 1763078400 were 13532095 with a Short Ratio of 1.88, compared to 1760486400 on 14948934. Therefore, it implies a Short% of Shares Outstanding of 13532095 and a Short% of Float of 1.06.
Dividends & Splits
With its trailing 12-month dividend rate of 2.82, MDT has a forward annual dividend rate of 2.82. Against a Trailing Annual Dividend Yield of 0.027638929. The stock’s 5-year Average Dividend Yield is 2.87. The current Payout Ratio is 77.47% for MDT, which recently paid a dividend on 2025-09-26 with an ex-dividend date of 2025-09-26. Stock splits for the company last occurred on 1999-09-27 when the company split stock in a 2:1 ratio.
Earnings Estimates
As of right now, 27.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $1.69, with high estimates of $1.71 and low estimates of $1.65.
Analysts are recommending an EPS of between $5.68 and $5.58 for the fiscal current year, implying an average EPS of $5.64. EPS for the following year is $6.11, with 31.0 analysts recommending between $6.25 and $5.98.
Revenue Estimates
In. The current quarter, 18 analysts expect revenue to total $8.89B. It ranges from a high estimate of $8.96B to a low estimate of $8.71B. As of. The current estimate, Medtronic Plc’s year-ago sales were $8.29BFor the next quarter, 18 analysts are estimating revenue of $9.63B. There is a high estimate of $9.68B for the next quarter, whereas the lowest estimate is $9.38B.
A total of 18 analysts have provided revenue estimates for MDT’s current fiscal year. The highest revenue estimate was $36.18B, while the lowest revenue estimate was $35.96B, resulting in an average revenue estimate of $36.06B. In the same quarter a year ago, actual revenue was $33.54BBased on 19 analysts’ estimates, the company’s revenue will be $38.08B in the next fiscal year. The high estimate is $38.77B and the low estimate is $37.05B.
